Our metabolomics analysis services can help you solve complex metabolic pathways, leading to significant breakthroughs in your project through biological research. We work towards making knowledge actionable for you through metabolomics.
We are OWL Metabolomics, a preferred supply partner in the field of metabolomics.
Our commitment is to guide our clients from basic sample analysis to profound insights, making biological sense out of complex data with our comprehensive reports and powerful data analytics technologies. With our specialized expertise in metabolomic profiling, we support and accelerate your research journey, ensuring your success by addressing your scientific questions, research and diagnostic needs.
Our services feature specific UHPLC-MS analytical platforms, designed to adapt to your requirements and provide a wide view of the metabolome. Our metabolite coverage spans over 1300 compounds, including a diverse range of classes with varying physicochemical properties and concentration ranges. We can deliver broad coverage of lipids, amino acids, bile acids, and metabolites from the central carbon metabolic pathways. We evaluate proposals individually and can offer custom method development. Detailed data analysis, including correlation studies and predictive algorithms, is available upon request.
Lipids play essential roles in biological systems, such as forming cell membranes, providing a hydrophobic medium for membrane proteins, and participating in signal transduction pathways. This platform utilizes methanol extraction and the analysis is performed by UHPLC coupled to a Time-of-Flight (ToF) mass spectrometer, allowing the analysis of the following lipid species:
⦁ Fatty acyls: non esterified fatty acids, oxidised fatty acids, N-acyl ethanolamines and acylcarnitines.
⦁ Sterol lipids: bile acids and steroids.
⦁ Glycerophospholipids (lyso-forms): lysophosphatidylethanolamines, lysophosphatidylinositols, lysophosphatidylglycerols and lysophosphatidylcholines, including ether-linked species.
⦁ Free sphingoid bases.
Fatty acyls: non esterified fatty acids, oxidised fatty acids, N-acyl ethanolamines and acylcarnitines.
Sterol lipids: bile acids and steroids.
Glycerophospholipids (lyso-forms): lysophosphatidylethanolamines, lysophosphatidylinositols, lysophosphatidylglycerols and lysophosphatidylcholines, including ether-linked species.
Free sphingoid bases.
Like Platform 1, this platform focuses on lipid analysis, employing chloroform/methanol extraction and the analysis is performed by UHPLC coupled to a Time-of-Flight (ToF) mass spectometer. This platform covers:
⦁ Fatty acyls: primary fatty amides.
⦁ Sterol lipids: Cholesterol esters, cholesterol and cholesteryl sulfate.
⦁ Sphingolipids: ceramides, monohexosylceramides and sphingomyelins.
⦁ Glycerolipids: monoacylglycerols, diacylglycerols and triacylglycerols.
⦁ Glycerophospholipids: phosphatidylethanolamines, phosphatidylinositols, and phosphatidylcholines, including ether-linked species.
Fatty acyls: primary fatty amides.
Sterol lipids: Cholesterol esters, cholesterol and cholesteryl sulfate.
Sphingolipids: ceramides, monohexosylceramides and sphingomyelins.
Glycerolipids: monoacylglycerols, diacylglycerols and triacylglycerols.
Glycerophospholipids: phosphatidylethanolamines, phosphatidylinositols, and phosphatidylcholines, including ether-linked species.
This platform analyses amino acids, the building blocks of proteins and metabolic intermediates. Using a derivatization method on methanol extracts it detects:
⦁ Amino acids.
⦁ Di- and tripeptides.
⦁ Amino acids derivatives.
Metabolomics is fast becoming a promising leading field in the practice of precision medicine. The close association between metabolites and phenotype can provide physicians and researchers with a powerful tool to obtain valuable, real-time information on the pathophysiological condition of an individual. Among other promising fields of study, metabolomics has proven useful to enable precise advancements in disease identification, characterization of disturbances, exploration of therapeutic targets, and discovery of biomarkers for diagnosis and treatment monitoring.
Within metabolomics, lipidomics is a crucial field for identifying disease-specific biomarkers and monitoring drug therapies. Through its focus on the diverse roles of lipids, lipidomics plays a pivotal role in disease diagnosis and prognosis.
OWL Metabolomics has optimized complete and highly productive metabolomic platforms. Our services include specific UHPLC-MS analytical platforms, tailored to your unique experimental needs and design. CTA: Read more about our Metabolomic services.
The strength of OWL Metabolomics lies in our multidisciplinary Scientific Team. With a fusion of scientific expertise, open communication and trust, our team creates enduring connections. We offer scientific guidance from experts in the field, and effective counsel for optimal experimental design from sample collection to statistical discussion.
OWL Metabolomics is more than just a service provider. According to our clients, our metabolomics specialists go above and beyond the essentials to make your experience fulfilling. We provide added value to your research by simplifying the interpretation of complex data, helping you to turn raw information into actionable metabolic insights.
At OWL Metabolomics, we are committed to delivering top-quality services for cutting-edge research. Our approach involves strict control over analytical procedures and the utilization of state-of-the-art facilities. We have a professional team of experts in the field ready to accommodate your needs. Here’s an overview of how we work:
Our qualified team of bioanalytical chemists gets in contact with you to discuss project details and provide technical guidance. We help design optimal experiments, including sample collection, preparation, analysis, and data processing, aiming for high-quality, fast, and cost-efficient results.
Sample prep is crucial in metabolomics, impacting metabolome coverage. We use specific methods based on the analysis requested, tailored to the sample type and metabolome portion of interest (e.g. lipids, amino acids).
Our platforms include liquid chromatography coupled with mass spectrometers (UPLC-MS), that offer selective and sensitive analyses for metabolite identification. Samples are analyzed in positive/negative ESI modes, scanning from m/z 50-1200 on a reverse-phase column chosen based on the application. OWL Metabolomics counts on both high- and low-resolution mass spectrometers that are used according to the analysis requirements.
Data handling is a challenging and critical step in metabolomics, requiring expertise in bioinformatics, statistics, and specialized software.
At OWL Metabolomics, we utilize powerful informatics and statistical applications to manage metabolomics datasets. Our analytical platforms are supported by state-of-the-art software and visualization tools, enabling transformation of complex data into informative charts and graphs. We employ chemometric tools like PCA, PLS-DA, OPLS, and univariate statistical analysis.
Our results package includes a detailed report of experimental methods, including a description of the results obtained from the data analysis and interpretation of these results. We also provide the obtained metabolomics data set.
Since 2006 we have established a strong track record in the field of metabolomics. Throughout our journey, we have successfully completed more than 350 service projects. Through these years we have led and been involved in a great number of R&D projects in a continuous dedication to advance scientific knowledge, contributing to the monitoring and diagnosis of human and animal health. Our work is endorsed by a great number of peer-reviewed scientific articles published.
We take great pride in the extensive recognition and certification from numerous health and governmental institutions we have received over the years. These certifications are a proof of our commitment to quality, innovation, and excellence in the field of metabolic sciences.